- Home
- DIT vs AGEN Comparison
DIT vs AGEN Comparison
Compare DIT & AGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- AGEN
- Stock Information
- Founded
- DIT 1981
- AGEN 1994
- Country
- DIT United States
- AGEN United States
- Employees
- DIT N/A
- AGEN N/A
- Industry
- DIT Food Distributors
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIT Consumer Discretionary
- AGEN Health Care
- Exchange
- DIT Nasdaq
- AGEN Nasdaq
- Market Cap
- DIT 78.7M
- AGEN 87.7M
- IPO Year
- DIT 1995
- AGEN 2000
- Fundamental
- Price
- DIT $115.50
- AGEN $6.07
- Analyst Decision
- DIT
- AGEN Buy
- Analyst Count
- DIT 0
- AGEN 4
- Target Price
- DIT N/A
- AGEN $13.00
- AVG Volume (30 Days)
- DIT 590.0
- AGEN 1.2M
- Earning Date
- DIT 07-17-2025
- AGEN 08-07-2025
- Dividend Yield
- DIT 0.87%
- AGEN N/A
- EPS Growth
- DIT N/A
- AGEN N/A
- EPS
- DIT 2.44
- AGEN N/A
- Revenue
- DIT $2,221,421,072.00
- AGEN $99,524,000.00
- Revenue This Year
- DIT N/A
- AGEN $12.69
- Revenue Next Year
- DIT N/A
- AGEN N/A
- P/E Ratio
- DIT $47.39
- AGEN N/A
- Revenue Growth
- DIT 7.47
- AGEN N/A
- 52 Week Low
- DIT $94.92
- AGEN $1.38
- 52 Week High
- DIT $166.00
- AGEN $18.74
- Technical
- Relative Strength Index (RSI)
- DIT 57.52
- AGEN 67.49
- Support Level
- DIT $100.08
- AGEN $4.34
- Resistance Level
- DIT $115.00
- AGEN $5.22
- Average True Range (ATR)
- DIT 5.01
- AGEN 0.46
- MACD
- DIT 1.78
- AGEN 0.02
- Stochastic Oscillator
- DIT 94.25
- AGEN 93.01
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).